{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:03:29Z","timestamp":1794747809757,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.parkreldis.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T02:16:27Z","timestamp":1641608187000},"page":"70-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Perivascular space in Parkinson's disease: Association with CSF amyloid\/tau and cognitive decline"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-2408","authenticated-orcid":false,"given":"Huimin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-8642","authenticated-orcid":false,"given":"Huijuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-6642","authenticated-orcid":false,"given":"Joanna M.","family":"Wardlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3267-0039","authenticated-orcid":false,"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.parkreldis.2022.01.002_bib1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.01.002_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2019.02.023","article-title":"An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF A\u00df42 and an APOE epsilon4 allele","volume":"127","author":"Shahid","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.parkreldis.2022.01.002_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/mds.27518","article-title":"Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study","volume":"33","author":"Delgado-Alvarado","year":"2018","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.01.002_bib4","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3233\/JAD-180367","article-title":"Targeted assessment of enlargement of the perivascular space in alzheimer's disease and vascular dementia subtypes implicates astroglial involvement specific to alzheimer's disease","volume":"66","author":"Boespflug","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.parkreldis.2022.01.002_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2022.01.002_bib6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","article-title":"Cerebrospinal fluid clearance in alzheimer disease measured with dynamic PET","volume":"58","author":"de Leon","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.01.002_bib7","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/ejn.14389","article-title":"Cerebrospinal fluids from Alzheimer's disease patients exhibit neurotoxic effects on neuronal cell cultures","volume":"50","author":"Jankeviciute","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.parkreldis.2022.01.002_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","article-title":"Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson's disease","volume":"27","author":"Ding","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.01.002_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"Progression marker, the Parkinson progression marker initiative (PPMI)","volume":"95","author":"Parkinson","year":"2011","journal-title":"Prog. Neurobiol."},{"issue":"8","key":"10.1016\/j.parkreldis.2022.01.002_bib10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2022.01.002_bib11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","article-title":"Pathologic correlates of incidental MRI white matter signal hyperintensities","volume":"43","author":"Fazekas","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.01.002_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","article-title":"Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease","volume":"41","author":"Doubal","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.01.002_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ijs.12054","article-title":"Enlarged perivascular spaces and cerebral small vessel disease","volume":"10","author":"Potter","year":"2015","journal-title":"Int. J. Stroke"},{"issue":"6","key":"10.1016\/j.parkreldis.2022.01.002_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00401-016-1552-2","article-title":"I. Parkinson's Progression Marker, CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study","volume":"131","author":"Kang","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"19","key":"10.1016\/j.parkreldis.2022.01.002_bib15","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","article-title":"Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls","volume":"89","author":"Mollenhauer","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2022.01.002_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2022.01.002_bib17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.25811","article-title":"I. Parkinson\u2019s progression marker, evolution of alzheimer\u2019s disease cerebrospinal fluid biomarkers in early Parkinson\u2019s disease","volume":"88","author":"Irwin","year":"2020","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.parkreldis.2022.01.002_bib18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/mds.27798","article-title":"Magnetic resonance imaging-visible perivascular spaces in basal ganglia predict cognitive decline in Parkinson's disease","volume":"34","author":"Park","year":"2019","journal-title":"Mov. Disord."},{"issue":"46","key":"10.1016\/j.parkreldis.2022.01.002_bib19","doi-asserted-by":"crossref","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","article-title":"Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain","volume":"33","author":"Iliff","year":"2013","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.01.002_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/STROKEAHA.118.020163","article-title":"Arterial stiffness is associated with basal ganglia enlarged perivascular spaces and cerebral small vessel disease load","volume":"49","author":"Riba-Llena","year":"2018","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.01.002_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","article-title":"D Colleagues from the fondation leducq transatlantic network of excellence on the role of the perivascular space in cerebral small vessel, perivascular spaces in the brain: anatomy, physiology and pathology","volume":"16","author":"Wardlaw","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.01.002_bib22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/mds.28473","article-title":"Global and regional changes in perivascular space in idiopathic and familial Parkinson's disease","volume":"36","author":"Donahue","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.01.002_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fnagi.2020.00161","article-title":"Dilated perivascular space in the midbrain may reflect dopamine neuronal degeneration in Parkinson's disease","volume":"12","author":"Li","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2022.01.002_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pneurobio.2017.08.007","article-title":"Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases","volume":"163\u2013164","author":"Sun","year":"2018","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.01.002_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","article-title":"Deposition of amyloid beta in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy","volume":"1862","author":"Keable","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.parkreldis.2022.01.002_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-beta and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.01.002_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920964077","article-title":"Unraveling pathophysiological mechanisms of Parkinson's disease: contribution of CSF biomarkers","volume":"15","author":"Farotti","year":"2020","journal-title":"Biomark. Insights"},{"issue":"4","key":"10.1016\/j.parkreldis.2022.01.002_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/brain\/awx003","article-title":"MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden","volume":"140","author":"Banerjee","year":"2017","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.parkreldis.2022.01.002_bib29","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1212\/WNL.0000000000011046","article-title":"Association of enlarged perivascular spaces and measures of small vessel and alzheimer disease","volume":"96","author":"Gertje","year":"2021","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:24:02Z","timestamp":1761179042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"alternative-id":["S1353802022000025"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.01.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perivascular space in Parkinson's disease: Association with CSF amyloid\/tau and cognitive decline","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}